DCC is excited to announce the launch of the new Cannabis Recall Portal, which offers an improved user interface and enhanced search functionality to help you quickly access recall information. Visit the recall portal today to track recalled products and stay informed.
Recall overview
The Department of Cannabis Control (DCC) is issuing this voluntary recall for a single Mary’s Medicinal Transdermal Compound product due to inaccurate labeling that reports more cannabinoid content than the product contains.
| Business Recall Date | 4/30/2024 |
| DCC Recall Publication Date | 4/30/2024 |
| Recall Type | Voluntary |
| Product Type | Cannabis Topical |
| Product Description | Mary’s Medicinal Transdermal Compound |
| Legal Business Name | RWC Manufacturing |
| Legal Business License Number | CDPH-10002341 |
| Packaged By | rcwmfg.com |
| Dates Sold | After February 13, 2024 |
Product details
This recall applies to the following Mary’s Medicinal Transdermal Compound product[s].
| Product | Batch Number | Product Size | UID Number | Date Packaged (Pkg) |
|---|---|---|---|---|
| FORMULA 300mg CBG/300 mg CBD/300mg THC 1:1:1 CBG:CBD:THC | MFC012424 | 1oz(28g) | 1A4060300001AF7000002257 | After February 8, 2024 |
Locations where the recalled product was sold
Product photos
What consumers need to know
If you purchased this product:
- If you are experiencing symptoms or any adverse reactions, contact your physician immediately.
- Check your package for the UID and batch number/s above.
- If the numbers match, dispose of the product or return it to the retailer for proper disposal.
What licensees need to know
DCC sent notices to all licensees with this product in their inventory with instructions about responding to this recall. Contact our team at recalls@cannabis.ca.gov if you have any questions.
